chromoblastomycosis is a chronic fungal infection of the skin and subcutaneous tissue.
着色芽生菌病是一种皮肤和皮下组织的慢性真菌感染。
diagnosis of chromoblastomycosis is confirmed by observing muriform cells in tissue samples.
通过观察组织样本中的分隔细胞，可确诊着色芽生菌病。
the primary treatment for chromoblastomycosis often involves prolonged systemic antifungal therapy.
着色芽生菌病的主要治疗方法通常包括长期的系统性抗真菌治疗。
prolonged exposure to soil and decaying vegetation is a major risk factor for chromoblastomycosis.
长期接触土壤和腐烂植被是患着色芽生菌病的主要危险因素。
itraconazole is frequently prescribed to manage mild to moderate cases of chromoblastomycosis.
伊曲康唑常被用于治疗轻度至中度的着色芽生菌病病例。
pathologists identify chromoblastomycosis by detecting dark-pigmented sclerotic bodies in biopsy specimens.
病理学家通过在活检标本中检测深色硬壳小体来识别着色芽生菌病。
without proper medical intervention, chromoblastomycosis can cause severe tissue fibrosis and disability.
如果没有适当的医疗干预，着色芽生菌病会导致严重的组织纤维化和残疾。
fonsecaea pedrosoi is the most common etiologic agent of chromoblastomycosis worldwide.
裴氏着色霉是全球范围内着色芽生菌病最常见的病原体。
cryosurgery is sometimes combined with drug therapy to treat refractory chromoblastomycosis lesions.
冷冻手术有时与药物治疗相结合，用于治疗难治性着色芽生菌病病损。
common clinical presentations of chromoblastomycosis include verrucous nodules and scaly plaques.
着色芽生菌病的常见临床表现包括疣状结节和鳞屑性斑块。
recognizing chromoblastomycosis early is crucial to preventing the need for extensive surgery.
早期识别着色芽生菌病对于避免进行广泛手术切除至关重要。
doctors differentiate chromoblastomycosis from cutaneous tuberculosis through laboratory culture and histopathology.
医生通过实验室培养和组织病理学将着色芽生菌病与皮肤结核区分开来。
chromoblastomycosis is a chronic fungal infection of the skin and subcutaneous tissue.
着色芽生菌病是一种皮肤和皮下组织的慢性真菌感染。
diagnosis of chromoblastomycosis is confirmed by observing muriform cells in tissue samples.
通过观察组织样本中的分隔细胞，可确诊着色芽生菌病。
the primary treatment for chromoblastomycosis often involves prolonged systemic antifungal therapy.
着色芽生菌病的主要治疗方法通常包括长期的系统性抗真菌治疗。
prolonged exposure to soil and decaying vegetation is a major risk factor for chromoblastomycosis.
长期接触土壤和腐烂植被是患着色芽生菌病的主要危险因素。
itraconazole is frequently prescribed to manage mild to moderate cases of chromoblastomycosis.
伊曲康唑常被用于治疗轻度至中度的着色芽生菌病病例。
pathologists identify chromoblastomycosis by detecting dark-pigmented sclerotic bodies in biopsy specimens.
病理学家通过在活检标本中检测深色硬壳小体来识别着色芽生菌病。
without proper medical intervention, chromoblastomycosis can cause severe tissue fibrosis and disability.
如果没有适当的医疗干预，着色芽生菌病会导致严重的组织纤维化和残疾。
fonsecaea pedrosoi is the most common etiologic agent of chromoblastomycosis worldwide.
裴氏着色霉是全球范围内着色芽生菌病最常见的病原体。
cryosurgery is sometimes combined with drug therapy to treat refractory chromoblastomycosis lesions.
冷冻手术有时与药物治疗相结合，用于治疗难治性着色芽生菌病病损。
common clinical presentations of chromoblastomycosis include verrucous nodules and scaly plaques.
着色芽生菌病的常见临床表现包括疣状结节和鳞屑性斑块。
recognizing chromoblastomycosis early is crucial to preventing the need for extensive surgery.
早期识别着色芽生菌病对于避免进行广泛手术切除至关重要。
doctors differentiate chromoblastomycosis from cutaneous tuberculosis through laboratory culture and histopathology.
医生通过实验室培养和组织病理学将着色芽生菌病与皮肤结核区分开来。
探索常用高频词汇